Funds-of-funds aren't dead, but they're different; Revolut's outsized round steals the spotlight; biopharma VC sees recalibration

February 26, 2026   |   Read online   |   Manage your subscription The Daily Pitch PE, VC and M&A Your edge on global private capital markets